Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: Proof of a concept

Gynecologic Oncology

Volumn 139, Issue 1, 2015, Pages 5-9

  Petrillo, M ^a,b   Vizzielli, G ^a   Fanfani, F ^a   Gallotta, V ^a   Cosentino, F ^a   Chiantera, V ^b,c   Legge, F ^d   Carbone, V ^a   Scambia, G ^a   Fagotti, A ^e  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF MOLISE   (Italy)

^d MIULLI GENERAL HOSPITAL   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Advanced epithelial ovarian cancer; Laparoscopy; Primary debulking surgery

Indexed keywords

ABDOMINAL SURGERY; ADULT; ADVANCED CANCER; ADVANCED EPITHELIAL OVARIAN CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CARCINOMATOSIS; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC TEST ACCURACY STUDY; DIAPHRAGMATIC CONFLUENT CARCINOMATOSIS; FEMALE; HUMAN; INTESTINE; INTESTINE RESECTION; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LAPAROTOMY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; OMENTUM; OVARY CARCINOMA; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECTOSIGMOIDECTOMY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SIGMOIDECTOMY; SPLEEN; SPLENECTOMY; STAGING LAPAROSCOPY; STOMACH; THORAX TUMOR; TUMOR VOLUME; UPPER ABDOMINAL SURGERY; BIOLOGICAL MODEL; GYNECOLOGIC SURGERY; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; STANDARDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; LAPAROSCOPY; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 84943362990     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.07.095     Document Type: Article

References (26)

1. I. Vergote, C.G. Tropé, F. Amant, and et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer N. Engl. J. Med. 363 2012 943 953
2. S. Kehoe, J. Hook, M. Nankivell, and et al. Chemotherapy or upfront surgery for newly diagnosed advanced ovarian cancer: results from the MRC CHORUS trial 2013 ASCO Annual Meeting. Abstract 5500. Presented June 1, 2013 2013
3. R.E. Bristow, R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J. Clin. Oncol. 20 2002 1248 1259
4. D.S. Chi, F. Musa, F. Dao, and et al. An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT) Gynecol. Oncol. 124 2012 10 14
5. A. du Bois, A. Reuss, E. Pujade-Lauraine, P. Harter, I. Ray-Coquard, and J. Pfisterer Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO) Cancer 115 2009 1234 1244
6. M. Peiretti, V. Zanagnolo, G.D. Aletti, and et al. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: surgical and oncological outcomes. Single institution experience Gynecol. Oncol. 119 2010 259 264
7. S.M. Eisenkop, N.M. Spirtos, R.L. Friedman, W.C. Lin, A.L. Pisani, and S. Perticucci Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study Gynecol. Oncol. 90 2003 390 396
8. J. Morrison, K. Haldar, S. Kehoe, and T.A. Lawrie Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer Cochrane Database Syst. Rev. 8 2012 CD005343
9. Available at website http://www.nccn.org/professionals/physician-gls/pdf/ovarian.pdf (accessed on 2nd July 2015)
10. A. Fagotti, G. Vizzielli, F. Fanfani, and et al. Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience Gynecol. Oncol. 131 2013 341 346
11. I. Zapardiel, and C.P. Morrow New terminology for cytoreduction in advanced ovarian cancer Lancet Oncol. 12 2011 214
12. E.L. Eisenhauer, N.R. Abu-Rustum, Y. Sonoda, and et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer Gynecol. Oncol. 103 2006 1083 1090
13. G.D. Aletti, S.C. Dowdy, K.C. Podratz, and W.A. Cliby Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer Gynecol. Oncol. 100 2006 283 287
14. F. Fanfani, A. Fagotti, V. Gallotta, and et al. Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery Gynecol. Oncol. 116 2010 497 501
15. P.A. Clavien, J. Barkun, M.L. de Oliveira, and et al. The Clavien-Dindo classification of surgical complications: five-year experience Ann. Surg. 250 2009 187 196
16. A. Fagotti, G. Ferrandina, F. Fanfani, and et al. Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma Am. J. Obstet. Gynecol. 199 2008 642.e1 642.e6
17. A. Fagotti, G. Vizzielli, P. De Iaco, and et al. A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer Am. J. Obstet. Gynecol. 209 2013 462.e1 462.e11
18. A. Fagotti, G. Ferrandina, F. Fanfani, and et al. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study Ann. Surg. Oncol. 13 8 Aug 2006 1156 1161
19. R.E. Bristow, L.R. Duska, N.C. Lambrou, and et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography Cancer 89 2000 1532 1540
20. J.S. Cowen, and M.A. Kelley Errors and bias in using the predictive scoring systems Crit. Care Clin. 10 1994 53
21. M. Petrillo, G. Ferrandina, A. Fagotti, and et al. Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapy Ann. Surg. Oncol. 20 2013 3955 3960
22. J.A. Rauh-Hain, C.C. Nitschmann, M.J. Worley Jr.; and et al. Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma Gynecol. Oncol. 129 2013 63 68
23. J.L. Brun, R. Rouzier, S. Uzan, and E. Daraï External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score Gynecol. Oncol. 110 2008 354 359
24. M.J. Rutten, M.M. Leeflang, G.G. Kenter, B.W. Mol, and M. Buist Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer Cochrane Database Syst. Rev. 2 2014 CD009786
25. S.L. Tucker, K. Gharpure, S.M. Herbrich, and et al. Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer Clin. Cancer Res. 20 2014 3280 3288
26. R.S. Suidan, P.T. Ramirez, D.M. Sarasohn, and et al. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer Gynecol. Oncol. 134 2014 468 472